Cross-validated subgroup-specific AUC values were similar to the overall AUC for hormone-receptor positive (0.836) and ER-positive (0.834), but not for triple-negative breast cancer (TNBC) patients (0.662, Supplementary Table S4). This evidence concerns the gene NR4A1 and triple-negative breast carcinoma.